FDA approves first maternal vaccine to prevent RSV, Pfizer’s single-dose Abrysvo
The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo is made by Pfizer.